logo

For the Inventor, By the Inventor

Madison, NJ, United States of America

Shui-on Leung

This inventor holds 24 USPTO granted patents, primarily in Bi-Specific Antibodies. Top assignee: Immunomedics, Inc.. Active years: 1995-2014.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shui-on Leung. Retrieved from https://idiyas.com/inventor/shui-on-leung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 24

% Patents Active = 58.3

Average Co-Inventor Count = 3.0

ph-index = 16

Forward Citations = 1,496(Granted Patents)


Location History:

  • Morris Township, NJ (US) (2002 - 2006)
  • Hong Kong, CN (2005 - 2011)
  • Morris Plains, NJ (US) (2011)
  • Madison, NJ (US) (1995 - 2014)

Company Filing History:

goldMedal24 out of 410 
 
Immunomedics, Inc.
 patents

Years Active: 1995-2014

Loading Chart...
Areas of Expertise:
Bi-Specific Antibodies
Immunoconjugates
Humanized Antibodies
Peptide-Based Agents
Tumor Vaccines
Anti-CD74 Antibodies
Granulocyte Antibodies
Carcinoembryonic Antigen
Immune Response
Clinical Use
Antibody Fragments
Pre-Targeting Therapy
24 patents (USPTO):Explore Patents
1. 8771694 - Immunoconjugates and humanized antibodies specific for B-cell lymphoma and leukemia cells (2014-07-08),
2. 7943343 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2011-05-17),
3. 7919087 - Internalizing anti-CD74 antibodies and methods of use (2011-04-05),
4. 7666415 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2010-02-23),
5. 7563439 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2009-07-21),
6. 7541440 - Chimeric, human and humanized anti-granulocyte antibodies and methods of use (2009-06-02),
7. 7429381 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2008-09-30),
8. 7413736 - Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications (2008-08-19),
9. 7348419 - Humanization of an anti-carcinoembryonic antigen anti-idiotype antibody as a tumor vaccine and for targeting applications (2008-03-25),
10. 7312318 - Internalizing anti-CD74 antibodies and methods of use (2007-12-25),
11. 7138103 - Use of bi-specific antibodies for pre-targeting diagnosis and therapy (2006-11-21),
12. 7074405 - Use of bi-specific antibodies for pre-targeting diagnosis and therapy (2006-07-11),
13. 7052872 - Bi-specific antibodies for pre-targeting diagnosis and therapy (2006-05-30),
14. 6962702 - Production and use of novel peptide-based agents for use with bi-specific antibodies (2005-11-08),
15. 6953675 - Landscaped antibodies and antibody fragments for clinical use (2005-10-11),

Title: The Innovative Journey of Inventor Shui-on Leung

Introduction: Shui-on Leung is a pioneering inventor based in Madison, NJ, known for his groundbreaking contributions to various fields through his inventive spirit and dedication to technological advancements.

Latest Patents: Shui-on Leung's recent patents include cutting-edge technologies in the fields of renewable energy, sustainable materials, and artificial intelligence, showcasing his commitment to creating a more efficient and sustainable future.

Career Highlights: With a career spanning over two decades, Shui-on Leung has established himself as a prominent figure in the world of innovation. His work has been recognized globally for its impact on industries such as healthcare, transportation, and telecommunications.

Collaborations: Throughout his career, Shui-on Leung has collaborated with leading research institutions, universities, and multinational corporations to bring his inventions to life. His collaborative efforts have resulted in the development of revolutionary products that have transformed the way we live and work.

Conclusion: Shui-on Leung's relentless pursuit of innovation and his passion for pushing the boundaries of what is possible have solidified his reputation as a visionary inventor. His contributions continue to inspire future generations of inventors to think creatively and strive for excellence in their pursuits.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…